MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • MassDevice Today
    • Cardiovascular
    • Clinical Trials
    • Legal News
    • Orthopedics
    • Regulatory/Compliance
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • More MedTech
    • Cosmetic/Aesthetic
    • Diabetes
    • Dialysis
    • Distribution
    • Imaging
    • Otolaryngology Ear, Nose & Throat
    • Pharma
    • Respiratory
    • Wound Care
  • Blog
  • DeviceTalks Podcasts
  • Resources
    • About MassDevice
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • White Papers
  • DeviceTalks
Home » Gottlieb: Shutdown means furloughs for 42% of FDA staff

Gottlieb: Shutdown means furloughs for 42% of FDA staff

January 22, 2018 By Brad Perriello Leave a Comment

Share

FDA 3D printingThe federal government shutdown means that 42% of the FDA’s personnel will go on furlough, commissioner Dr. Scott Gottlieb said today.

“FDA’s current shutdown plan provides for 58% of workforce continuing to work and 42% furloughed. The number of FDA employees continuing to work in this shutdown is projected to be an increase from past shutdowns. FDA user fee programs have grown significantly since 2013,” Gottlieb wrote on Twitter.

The other 58% will stay on duty to conduct surveillance of adverse events for medical devices, drugs and other medical products, Gottlieb said in another Twitter message.

“FDA personnel will continue to review food and drug imports despite the lapse in appropriated funding. This work is mission critical to protecting consumers/patients from harmful products that may cross into the U.S.,” he wrote. “FDA currently has access to carryover user fee funds that allow us to continue to review/approve some types of medical product applications. Ensuring patients have access to novel, beneficial medical products is key part of our work to protect & promote public health.”

The federal safety watchdog will also continue to monitor influenza activity and the supply of anti-viral medications, working with the Centers for Disease Control & Prevention, Gottlieb added. Food recalls and monitoring will also continue, he said.

“The hurricane recovery has been a key focus for FDA; and this mission critical work will continue in earnest during the shutdown. We will not stop working to alleviate the urgent IV saline shortage situation,” Gottlieb concluded.

Filed Under: Food & Drug Administration (FDA), Regulatory/Compliance

In case you missed it

  • Topcon’s ocular diagnostic instrument lands 510(k) clearance
  • UPDATE: Senate votes to end federal shutdown, pause medical device tax
  • Adhesys Medical wins CE Mark for Flix surgical adhesive
  • Gottlieb: Shutdown means furloughs for 42% of FDA staff
  • SFC Fluidics inks deal with JDRF to develop automated insulin delivery system
  • SurModics wins FDA nod for Telemark crossing microcatheter
  • Braeburn dealt setback over monthly, weekly opioid abuse therapy
  • Medrobotics wins expanded indications for Flex robot-assisted surgery device
  • Senate to vote on ending shutdown
  • Xtant Medical plans refinancing, 12-to-1 reverse stock split
  • 7 medtech stories we missed this week: Jan. 19, 2018
  • Laminate Medical launches study of VasQ hemodialysis fistula device
  • Audax begins recapitalization of Belmont Instruments
  • Medizone to launch further AscepticSure testing in pursuit of FDA de novo pathway
  • EpiPen shortage in Canada to last until March
  • These medtech companies raised the most VC last year
  • Centinel Spine reports $132m funding round

RSS From Medical Design & Outsourcing

  • These medtech companies raised the most VC last year
    Perhaps there’s a ray of hope that venture capital funding is recovering a bit for the medical device industry. VC firms invested more than $2.8 billion in 2017, an increase of more than $647 million from 2016, according to the MoneyTree Report from PricewaterhouseCoopers (PwC) and CB Insights. There were a total 229 deals involving […]
  • Medtech stories we missed this week: Jan. 19, 2018
    From Privi Medical’s FDA clearance to OrthoXel getting FDA clearance and CE Mark approval, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Privi Medical wins FDA nod for hemorrhoid device Privi Medical has received FDA clearance for its Instalief Hemorrhoids Treatment device, according to a Jan. 18 news […]
  • How blockchains could empower patients and secure data
    Blockchains are best known as the technology behind cryptocurrencies such as Bitcoin. But the founders of a young Atlanta-based company called Patientory think they could have another important use – securing health data and empowering patients along the way. Secure access to patient data is a major issue for the healthcare industry. Patients have a […]
  • Phillips-Medisize’s increased business to benefit Molex plant in Arkansas
    Phillips-Medisize today announced a doubling of production for an undisclosed fast-growing medical customer with a take-home diagnostic kit for cancer detection – with benefits for the plant that Phillips-Medisize’s parent Molex runs in Little Rock, Ark. Phillips-Medisize, which is based in Hudson, Wis., did not disclose the identity of the customer, which it described as a leader […]
  • GlobTek touts EAC-certified off-the-shelf power supplies for medical, other applications
    GlobTek is touting the wide variety of EAC-certified power supplies that it is offering for applications including medical, information technology equipment, household and more. A full list is available on the Northvale, N.J.–based company’s website.  EAC certification, formerly known as the Russian GOST-R certification, implements a new logo (EAC mark)  – and involves the implementation […]
  • Robotic spine surgery is getting a real-time image guide boost
    For the first time, surgeons at Johns Hopkins Hospital were able to harness real-time image guidance during a robotic spine surgery procedure to insert screws into a patient’s spine. The process offers a marked improvement over the accuracy of placement compared with other image-guided procedures. Dr. Nicholas Theodore – professor of neurosurgery at the Johns Hopkins University […]
  • Cardiovascular Systems inks partnerships with OrbusNeich, Integer
    Cardiovascular Systems (Nasdaq: CSII) announced today that it is expanding its product portfolio through new partnerships with OrbusNeich and Integer. The OrbusNeich partnership makes St. Paul, Minn.–based CSI the exclusive U.S. distributor of Hong Kong–based OrbusNeich‘s balloon products. The deal with Frisco, Texas–based Integer (NYSE: ITGR) involves Integer producing CSI-branded Zilient guidewires. Cardiovascular Systems CEO […]
  • FDA to expedite release of recall information
    Douglas Stearn, FDA When FDA identifies that a product it regulates violates the law, it protects the public by working with the manufacturer and distributors to facilitate the product’s recall (i.e., removal from the marketplace or product correction). Among other actions, FDA assures that the public is warned when products present the most significant public […]
  • IRS won’t enforce penalties on medical device tax
    The U.S. Internal Revenue Service yesterday said it won’t enforce penalties on companies making late payments on the medical device tax for the first three months of this year. The 2.3% excise tax on U.S. medical device revenues was in effect for two years before a two-year moratorium went into effect for 2016 and 2017. It went […]
  • Is tax reform good or bad for medical device companies?
    Medical device companies and others in the healthcare sector stand to benefit from the tax reform Congress passed at the end of 2017, but the picture isn’t entirely rosy, according to a new report from S&P Global Ratings. In many ways, the report offers a corrective to the bullish statements coming from corporate CEOs such […]
  • FDA releases top 3 medical device regulation goals
    FDA medical device regulators’ top priorities over the next three years include improving employee engagement, increasing simplicity and building collaborative communities, according to a new Strategic Priorities paper that FDA’s CDRH released today. The agency said the priorities further its overall goal of providing Americans with more timely access to the latest high-quality, safe and effective medical devices. […]

Leave a Reply Cancel reply

You must be logged in to post a comment.

Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Privacy
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Connect with us on Google PlusGoogle+

Copyright © 2018 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy